US Broker Ratings

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Powerhouse with 376% Return on Equity

Rigel Pharmaceuticals, Inc. (RIGL) stands out in the biotechnology sector, showcasing remarkable metrics that could capture the attention of investors seeking growth in the healthcare domain...

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 65% Potential Upside in Biotech Innovation

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company with a market cap of $425.91 million, presents an intriguing opportunity for investors seeking exposure to the..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Healthcare Innovator with Over 100% Potential Upside

Alpha Teknova, Inc. (NASDAQ: TKNO) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Hollister, California, this..

Evolent Health, Inc (EVH) Stock Analysis: A Potential 130% Upside Amidst Industry Challenges

Evolent Health, Inc (NYSE: EVH), a notable player in the healthcare sector, has garnered attention for its innovative approach to managing specialty care services, particularly in..

Harrow, Inc. (HROW) Stock Analysis: Eyeing an 89.59% Upside in the Ophthalmic Pharmaceutical Arena

Harrow, Inc. (HROW) is capturing investor attention with its promising potential upside of nearly 90%, as indicated by recent analyst ratings. Operating in the healthcare sector,..

Aveanna Healthcare (AVAH) Stock Analysis: Navigating Growth in Home Healthcare with a 2.14% Upside

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is carving a niche in the healthcare sector by focusing on delivering patient-centered care directly to homes, thereby minimizing the..

89bio, Inc. (ETNB) Investor Outlook: Potential 104% Upside as Biotech Innovator Gains Ground

Investors with a keen eye on the biotechnology sector may want to consider 89bio, Inc. (NASDAQ: ETNB), a promising clinical-stage biopharmaceutical company currently making waves with..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 13% Potential Upside Amidst Strong Buy Ratings

BioLife Solutions, Inc. (NASDAQ: BLFS), a pivotal player in the healthcare sector’s medical instruments and supplies industry, is catching the eyes of investors with its promising..

Pediatrix Medical Group, Inc. (MD) Stock Report: Navigating Market Challenges with Strong Free Cash Flow

Investors keen on the healthcare sector may want to keep an eye on Pediatrix Medical Group, Inc. (MD), a prominent player in the medical care facilities..

Evotec SE (EVO) Stock Analysis: Unveiling a 34% Potential Upside in the Biotech Frontier

Evotec SE (NASDAQ: EVO), a prominent player in the healthcare sector, specifically within the niche of drug manufacturing, stands out as an intriguing opportunity for investors..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator Eyes 138% Potential Upside

Wave Life Sciences Ltd. (WVE), a Singapore-based biotechnology firm, is capturing investor interest with its innovative approach to RNA medicine. The company, which operates in the..

Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Analyzing a Potential 92% Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a noteworthy player in the biotechnology sector, particularly within the healthcare industry, where it has carved out a niche in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 23.09% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) has emerged as a promising player in the healthcare sector, specifically within the medical care facilities industry. With a market..

Astrana Health Inc. (ASTH) Stock Analysis: Impressive 36.40% Potential Upside Amid Strong Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH) has been making waves in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.52..

10x Genomics, Inc. (TXG) Stock Analysis: Investor Outlook with 8.45% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG) is capturing investor attention with its innovative contributions to the healthcare sector. Operating primarily within the Health Information Services industry, 10x..

Celldex Therapeutics (CLDX) Stock Analysis: Exploring a Potential 115% Upside in the Biotech Space

For investors keen on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) represents an intriguing opportunity. With a market capitalization of $1.64 billion, this New Jersey-based..

Viridian Therapeutics (VRDN) Stock Analysis: Exploring a 65% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology firm situated in the healthcare sector, has been drawing considerable attention from investors, particularly due to its promising pipeline..

Neogen Corporation (NEOG) Stock Analysis: Understanding the 29.84% Potential Upside

Investors looking to tap into the healthcare sector’s diagnostic and research sub-industry might find Neogen Corporation (NASDAQ: NEOG) to be an intriguing candidate. With a market..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unpacking a 31.74% Upside Potential

Investors are continually seeking opportunities in the healthcare sector, and The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing case with a notable 31.74% upside potential...

Mineralys Therapeutics, Inc. (MLYS) Stock Report: Navigating Biotech’s Potential with a 14.88% Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the healthcare sector, specifically within the biotechnology industry. With a current market cap of $3.04 billion, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds